Extended Mass Spec Imaging Services Now Available from Protea Biosciences

14 Apr 2013
Sarah Thomas
Associate Editor

Product news

Protea Biosciences, a leading developer of innovative bioanalytical products and services, announced today the release of an extended mass spectrometry imaging (MSI) service offering from the Mass Spec Imaging Center (MSIC™). This new service portfolio offers advanced MSI services using Protea’s proprietary LAESI DP-1000 Direct Ionization System as well as MALDI (Matrix-Assisted Laser Desorption/Ionization) mass spectrometry for a wide variety of sample types and applications.

“This new portfolio of services offers researchers an opportunity to ‘detect’ where their molecules of interest reside in a biological matrix,” said Alessandro Baldi PhD, Protea’s Vice President and General Manager. “This spatial information offers critical insight for researchers working in the fields like metabolomics, biomarker discovery, drug discovery, and histopathology.”

To highlight this extended service portfolio, Protea announced a Spring Webinar Series, which discusses various applications and technologies for mass spectrometric imaging. These webinars cover topics ranging from biomarker discovery to drug distribution profiling and in vivo applications using the LAESI technology.

The MSIC also serves as a demonstration and training facility to help researchers learn more about mass spectrometry imaging using the tools and techniques developed at Protea.

Links

Tags

Mass SpectrometryMass spectrometry (MS) is a powerful analytical technique used to identify and quantify molecules based on the mass-to-charge ratio of gas-phase ions. It provides detailed information about the structure, composition, and properties of compounds and is widely used across fields such as environmental monitoring, materials science, drug discovery and development, food and beverage testing, and wider chemical research. Key MS techniques include tandem mass spectrometry (MS/MS), liquid chromatography–mass spectrometry (LS-MS) and inductively coupled plasma (ICP-MS). Choosing from these wide range of techniques and technologies can be a daunting task, so keep up to date with scientific applications, performance expectations, and customer reviews here all in one place. Visit our product directory to receive quotes direct from the manufacturer. BiomarkersBiomarkers are biological markers which can be measured and evaluated to indicate a biological state. The use of biomarkers in research and diagnosis can indicate a normal or disease state or drug response of cells / tissues. Biomarkers include genetic markers, cell surface markers such as antigens, antibodies or receptors and secreted molecules such as cytokines. An assay system is required for identification of biomarkers. :ImagingImaging techniques are essential for obtaining visual representations of samples to understand structures, processes, and function in biological, chemical, and physical research. These tools range from traditional light microscopy to advanced imaging modalities like MRI and electron microscopy, providing researchers with valuable data for diagnostics, drug discovery, and material analysis. Explore imaging solutions in our peer-reviewed product directory to compare products, check reviews, and get pricing directly from manufacturers.Biomarker DiscoveryClinical biomarkers refer to substances related to known medical conditions that can be accurately measured <i>in vitro</i>. Biomarkers can be used to diagnose presence of a disease and indicate disease severity. The discovery of new biomarkers is incredibly valuable in the field of diagnostics.Drug DevelopmentDrug development refers to the process of bringing a new drug to market.